financetom
Business
financetom
/
Business
/
FreightCar America's Q2 revenue beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FreightCar America's Q2 revenue beats estimates
Aug 4, 2025 1:41 PM

Overview

* FreightCar America ( RAIL ) Q2 revenue of $118.6 mln beats analyst expectations

* Adjusted EPS of $0.11 surpasses estimates, reflecting operational flexibility

* Adjusted EBITDA of $10 mln exceeds analyst expectations, per LSEG data

Outlook

* FreightCar America ( RAIL ) reaffirms fiscal 2025 revenue guidance of $530-$595 mln

* Company expects railcar deliveries of 4,500-4,900 units in fiscal 2025

* FreightCar America ( RAIL ) projects fiscal 2025 adjusted EBITDA of $43-$49 mln

Result Drivers

* ORDER INTAKE - Strong order intake driven by operational flexibility, with 1,226 new railcar orders valued at $106.9 mln

* GROSS MARGIN IMPROVEMENT - Gross margin expanded by 250 basis points to 15%, attributed to improved productivity and a richer product mix

* MARKET AGILITY - Company's agility in rebuilds and conversions enabled capturing opportunities in a dynamic market

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $118.62 $114.90

Revenue mln mln (3

Analysts

)

Q2 Beat $0.11 $0.06 (2

Adjusted Analysts

EPS )

Q2 EPS $0.34

Q2 Net $11.68

Income mln

Q2 Beat $10 mln $9 mln

Adjusted (3

EBITDA Analysts

)

Q2 Gross 15.0%

Margin

Q2 Gross $17.82

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the heavy machinery & vehicles peer group is "buy."

* Wall Street's median 12-month price target for FreightCar America Inc ( RAIL ) is $10.00, about 2% above its August 1 closing price of $9.80

* The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 9 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved